APRETUDE Trademark

Trademark Overview

On Friday, November 9, 2012, a trademark application was filed for APRETUDE with the United States Patent and Trademark Office. The USPTO has given the APRETUDE trademark a serial number of 85775770. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, August 8, 2023. This trademark is owned by Glaxo Group Limited. The APRETUDE trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines ] * Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders *
apretude

General Information

Serial Number85775770
Word MarkAPRETUDE
Filing DateFriday, November 9, 2012
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, August 8, 2023
Registration Number5056992
Registration DateTuesday, October 11, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, line 4-10, "Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines" is deleted, and "Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders" is inserted.
Goods and Services[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines ] * Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders *

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 16, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIIV HEALTHCARE UK (NO.3) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Tuesday, September 12, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 8, 2023AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Tuesday, August 8, 2023AFFIDAVIT UNDER SECT 15 ABANDONED
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 1, 2023PETITION TO DIRECTOR GRANTED
Monday, July 31, 2023ASSIGNED TO PETITION STAFF
Friday, May 5, 2023TEAS PETITION TO DIRECTOR RECEIVED
Friday, May 5, 2023TEAS SECTION 7 REQUEST RECEIVED
Monday, February 6, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, February 6, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 6, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 20, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 11, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 11, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 8, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 5, 2016NOTICE OF ALLOWANCE CANCELLED
Sunday, June 26, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2016SOU EXTENSION 5 GRANTED
Monday, December 21, 2015SOU EXTENSION 5 FILED
Monday, December 21, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, June 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2015SOU EXTENSION 4 GRANTED
Monday, June 1, 2015SOU EXTENSION 4 FILED
Monday, June 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 1, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014SOU EXTENSION 3 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 3 FILED
Tuesday, December 2, 2014SOU TEAS EXTENSION RECEIVED
Thursday, July 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 16, 2014SOU EXTENSION 2 GRANTED
Monday, June 23, 2014SOU EXTENSION 2 FILED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 23, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2013SOU EXTENSION 1 GRANTED
Monday, December 16, 2013SOU EXTENSION 1 FILED
Monday, December 16, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 26, 2013ASSIGNED TO LIE
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2013EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Friday, November 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 13, 2012NEW APPLICATION ENTERED

Related Keywords

apretude pharmaceutical substances treatment preparations disorders diseases immune viral infectious related